HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

From Oncology Today with Dr Neil Love Dr. Neil Love

Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer.

CME information and select publications here.

Community discussion

Join the conversation

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

You May Also Like

Deep Marine Scenes

Eye On The Sky

The Grave Talks | Haunted, Paranormal & Supernatural

Real Ghost Stories Online

Sage Sociology

La Science, CQFD

Planetary Radio: Space Exploration, Astronomy and Science

Experimental History

John Michael Godier's Event Horizon

DarshanTalks Podcast